Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine

Esophageal cancer is often diagnosed at the late stage when cancer has already spread and is characterized by a poor prognosis. Therefore, early diagnosis is vital for a better and efficient treatment outcome. Upper endoscopy with biopsy is the standard diagnostic tool for esophageal cancer but is c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Onyisi Christiana Didamson, Heidi Abrahamse
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/25ea3ce565d941e1af635761b50126e1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:25ea3ce565d941e1af635761b50126e1
record_format dspace
spelling oai:doaj.org-article:25ea3ce565d941e1af635761b50126e12021-11-25T18:42:14ZTargeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine10.3390/pharmaceutics131119431999-4923https://doaj.org/article/25ea3ce565d941e1af635761b50126e12021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1943https://doaj.org/toc/1999-4923Esophageal cancer is often diagnosed at the late stage when cancer has already spread and is characterized by a poor prognosis. Therefore, early diagnosis is vital for a better and efficient treatment outcome. Upper endoscopy with biopsy is the standard diagnostic tool for esophageal cancer but is challenging to diagnose at its premalignant stage, while conventional treatments such as surgery, chemotherapy, and irradiation therapy, are challenging to eliminate the tumor. Photodynamic diagnosis (PDD) and therapy (PDT) modalities that employ photosensitizers (PSs) are emerging diagnostic and therapeutic strategies for esophageal cancer. However, some flaws associated with the classic PSs have limited their clinical applications. Functionalized nanomedicine has emerged as a potential drug delivery system to enhance PS drug biodistribution and cellular internalization. The conjugation of PSs with functionalized nanomedicine enables increased localization within esophageal cancer cells due to improved solubility and stability in blood circulation. This review highlights PS drugs used for PDD and PDT for esophageal cancer. In addition, it focuses on the various functionalized nanomedicine explored for esophageal cancer and their role in targeted PDD and PDT for diagnosis and treatment.Onyisi Christiana DidamsonHeidi AbrahamseMDPI AGarticleesophageal cancerphotodynamic diagnosis (PDD)photodynamic therapy (PDT)photosensitizer (PS)functionalized nanomedicinenanoparticles (NP)Pharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1943, p 1943 (2021)
institution DOAJ
collection DOAJ
language EN
topic esophageal cancer
photodynamic diagnosis (PDD)
photodynamic therapy (PDT)
photosensitizer (PS)
functionalized nanomedicine
nanoparticles (NP)
Pharmacy and materia medica
RS1-441
spellingShingle esophageal cancer
photodynamic diagnosis (PDD)
photodynamic therapy (PDT)
photosensitizer (PS)
functionalized nanomedicine
nanoparticles (NP)
Pharmacy and materia medica
RS1-441
Onyisi Christiana Didamson
Heidi Abrahamse
Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
description Esophageal cancer is often diagnosed at the late stage when cancer has already spread and is characterized by a poor prognosis. Therefore, early diagnosis is vital for a better and efficient treatment outcome. Upper endoscopy with biopsy is the standard diagnostic tool for esophageal cancer but is challenging to diagnose at its premalignant stage, while conventional treatments such as surgery, chemotherapy, and irradiation therapy, are challenging to eliminate the tumor. Photodynamic diagnosis (PDD) and therapy (PDT) modalities that employ photosensitizers (PSs) are emerging diagnostic and therapeutic strategies for esophageal cancer. However, some flaws associated with the classic PSs have limited their clinical applications. Functionalized nanomedicine has emerged as a potential drug delivery system to enhance PS drug biodistribution and cellular internalization. The conjugation of PSs with functionalized nanomedicine enables increased localization within esophageal cancer cells due to improved solubility and stability in blood circulation. This review highlights PS drugs used for PDD and PDT for esophageal cancer. In addition, it focuses on the various functionalized nanomedicine explored for esophageal cancer and their role in targeted PDD and PDT for diagnosis and treatment.
format article
author Onyisi Christiana Didamson
Heidi Abrahamse
author_facet Onyisi Christiana Didamson
Heidi Abrahamse
author_sort Onyisi Christiana Didamson
title Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
title_short Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
title_full Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
title_fullStr Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
title_full_unstemmed Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
title_sort targeted photodynamic diagnosis and therapy for esophageal cancer: potential role of functionalized nanomedicine
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/25ea3ce565d941e1af635761b50126e1
work_keys_str_mv AT onyisichristianadidamson targetedphotodynamicdiagnosisandtherapyforesophagealcancerpotentialroleoffunctionalizednanomedicine
AT heidiabrahamse targetedphotodynamicdiagnosisandtherapyforesophagealcancerpotentialroleoffunctionalizednanomedicine
_version_ 1718410759665352704